Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF

被引：0
|
作者：
Selvaraj, S. [1 ]
Claggett, B. L. [2 ]
Veldhuisen, D. V. [3 ]
Anand, I. S. [4 ]
Pieske, B. [5 ]
Rouleau, J. L. [6 ]
Zile, M. R. [7 ]
Shi, V. C. [8 ]
Lelkowite, M. P. [8 ]
McMurray, J. J., V [9 ]
Solomon, S. D. [2 ]
机构：
[1] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] Univ Minnesota, Minneapolis, MN USA
[5] German Ctr Cardiovasc Res, Berlin, Germany
[6] Univ Montreal, Montreal, PQ, Canada
[7] Med Univ South Carolina, Charleston, SC 29425 USA
[8] Novartis, E Hanover, NJ USA
[9] Cardiovasc Res Ctr Glasgow, Glasgow, Lanark, Scotland
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1066 / 1066
页数：1
相关论文
共 50 条
  • [1] Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction:PARAGON-HF
    Selvaraj, Senthil
    Claggett, Brian L.
    Pfeffer, Marc A.
    Desai, Akshay S.
    Mc Causland, Finnian R.
    McGrath, Martina M.
    Anand, Inder S.
    van Veldhuisen, Dirk J.
    Kober, Lars
    Janssens, Stefan
    Cleland, John G. F.
    Pieske, Burkert
    Rouleau, Jean L.
    Zile, Michael R.
    Shi, Victor C.
    Lefkowitz, Martin P.
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) : 2093 - 2101
  • [2] The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
    Gronda, Edoardo
    Vanoli, Emilio
    Iacoviello, Massimo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0L) : L77 - L81
  • [3] EFFECT OF SACUBITRIL/VALSARTAN ON SERUM LIPIDS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF
    Selvaraj, Senthil
    Claggett, Brian
    Packer, Milton
    Zannad, Faiez
    Ananda, Inderjit
    Pieske, Burkert
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John
    Solomon, Scott
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 556 - 556
  • [4] Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial
    Ostrominski, John W.
    Claggett, Brian L.
    Packer, Milton
    Pfeffer, Marc A.
    Lam, Carolyn S. P.
    Zile, Michael R.
    Desai, Akshay S.
    Jhund, Pardeep S.
    Lefkowitz, Martin
    Mcmurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (11) : 1494 - 1503
  • [5] Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial
    Lund, Lars H.
    Savarese, Gianluigi
    Venkateshvaran, Ashwin
    Benson, Lina
    Lundberg, Anna
    Donal, Erwan
    Daubert, Jean-Claude
    Oger, Emmanuel
    Linde, Cecilia
    Hage, Camilla
    ESC HEART FAILURE, 2022, 9 (01): : 164 - 177
  • [6] Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial
    Chatur, Safia
    Claggett, Brian L.
    Vardeny, Orly
    Jering, Karola
    Desai, Akshay S.
    Pfeffer, Marc A.
    Lefkowitz, Martin
    McMurray, John J., V
    Solomon, Scott D.
    Vaduganathan, Muthiah
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (01) : 87 - 94
  • [7] Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF
    Wang, Xiaowen
    Vardeny, Orly
    Claggett, Brian
    Vaduganathan, Muthiah
    Hegde, Sheila M.
    Skali, Hicham
    Pabon, Maria A.
    Foa, Alberto
    Chatur, Safia
    Kosztin, Annamaria
    O'Meara, Eileen
    Rouleau, Jean
    Redfield, Margaret
    Lam, Carolyn S. P.
    Zile, Michael
    Packer, Milton
    Shah, Amil M.
    Cikes, Maja
    Gori, Mauro
    Merkely, Bela
    Pfeffer, Marc A.
    Mcmurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2025, 27 (01) : 96 - 106
  • [8] Duration of heart failure with preserved ejection fraction and treatment with sacubitril/valsartan: insights from the PARAGON-HF trial
    Ostrominski, John
    Claggett, B.
    Packer, M.
    Pfeffer, M.
    Lam, C.
    Zile, M.
    Desai, A.
    Jhund, P.
    Lefkowitz, M.
    Mcmurray, J.
    Solomon, S.
    Vaduganathan, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 119 - 119
  • [9] Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF
    Dewan, Pooja
    Shen, Li
    Ferreira, Joao Pedro
    Jhund, Pardeep S.
    Anand, Inder S.
    Chandra, Alvin
    Chiang, Lu-May
    Claggett, Brian
    Desai, Akshay S.
    Gong, Jianjian
    Lam, Carolyn S. P.
    Lefkowitz, Martin P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Redfield, Margaret M.
    Rouleau, Jean L.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Solomon, Scott D.
    McMurray, John J. V.
    CIRCULATION, 2024, 150 (04) : 272 - 282
  • [10] SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF
    Selvaraj, Senthil
    Claggett, Brian
    Bohm, Michael
    Anker, Stefan D.
    Vaduganathan, Muthiah
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 680 - 680
12345